Literature DB >> 30239516

Chemotherapy-Induced Peripheral Neuropathy: Use of an Electronic Care Planning System to Improve Adherence to Recommended Assessment and Management Practices.

Robert Knoerl1, Celia Bridges2, Gloria L Smith3, James J Yang2, Grace Kanzawa-Lee2, Ellen M L Smith2.   

Abstract

BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is often inadequately assessed and managed by advanced practice providers.
OBJECTIVES: The aim is to explore the impact of CIPN assessment training and electronic care planning system (CPS) use on CIPN assessment documentation and guidelines adherence.
METHODS: The authors used a pre-/post-test, prospective design with two retrospective chart reviews. Six providers received CIPN assessment training and used the CPS to manage CIPN for 75 women receiving neurotoxic chemotherapy.
FINDINGS: CPS use significantly improved documentation of numbness and nonpainful CIPN management strategies but had no effect on documentation of additional assessment variables or painful CIPN management.

Entities:  

Keywords:  chemotherapy-induced peripheral neuropathy; clinical guidelines; symptom assessment

Mesh:

Substances:

Year:  2018        PMID: 30239516     DOI: 10.1188/18.CJON.E134-E140

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  4 in total

1.  Characterizing patient-clinician chemotherapy-induced peripheral neuropathy assessment and management communication approaches.

Authors:  Robert Knoerl; Ellen M L Smith; Amy Han; Allison Doe; Katelyn Scott; Donna L Berry
Journal:  Patient Educ Couns       Date:  2019-04-09

2.  Exploring Patients' Understanding of Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Robert Knoerl; Donna L Berry; Jeffrey Meyerhardt; Kaitlen Reyes; Elahe Salehi; Jennifer S Gewandter
Journal:  J Cancer Educ       Date:  2022-08-05       Impact factor: 1.771

3.  Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy.

Authors:  Robert Knoerl; Edie Weller; Barbara Halpenny; Donna Berry
Journal:  BMC Cancer       Date:  2018-12-04       Impact factor: 4.430

4.  Exploring the impact of a decision support algorithm to improve clinicians' chemotherapy-induced peripheral neuropathy assessment and management practices: a two-phase, longitudinal study.

Authors:  Robert Knoerl; Emanuele Mazzola; Fangxin Hong; Elahe Salehi; Nadine McCleary; Jennifer Ligibel; Kaitlen Reyes; Donna L Berry
Journal:  BMC Cancer       Date:  2021-03-06       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.